{"id":"W3204843825","doi":"10.1016/j.annonc.2021.08.517","title":"234P Effect of palbociclib (PAL) + endocrine therapy (ET) on time to chemotherapy (TTC) across subgroups of patients (pts) with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC): Post hoc analyses from PALOMA-2 (P2) and PALOMA-3 (P3)","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Palbociclib; Internal medicine; Human Epidermal Growth Factor Receptor 2; Chemotherapy; Oncology; Endocrine system; Chemotherapy regimen; Endocrinology; Hormone receptor; Receptor; Hormone; Cancer; Metastatic breast cancer; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000277245,0.0007068826,0.002322249,0.0002137475,0.0001253381,0.00001474514,0.0002629099,0.0002448871,0.001257185],"category_scores_gemma":[0.0001808163,0.0005469237,0.0003068006,0.0006441353,0.000718668,0.0002890925,0.0001146076,0.000398707,0.00001301181],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002052659,"about_ca_system_score_gemma":0.000261959,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001016433,"about_ca_topic_score_gemma":0.0002620101,"domain_scores_codex":[0.9959976,0.0007055784,0.0009799949,0.0009406408,0.0006399704,0.0007362263],"domain_scores_gemma":[0.9948838,0.001289794,0.001042762,0.0005942093,0.001841111,0.0003482848],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.06365337,0.001658299,0.04119324,0.0001428103,0.002032805,0.0000390895,0.003554291,0.00001733651,0.5821313,0.00001257772,0.0003105608,0.3052544],"study_design_scores_gemma":[0.01633329,0.02567662,0.460162,0.000384372,0.00007917891,0.00001643459,0.0002850261,0.000002389587,0.4955748,0.0000484518,0.001079099,0.0003584178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9874635,0.002314352,0.00004186385,0.004306987,0.0001058251,0.001265405,0.004284631,0.0000495499,0.0001678248],"genre_scores_gemma":[0.9913093,0.003401369,0.001734135,0.002444182,0.0001602591,0.0001617173,0.0005088225,0.000130883,0.0001493727],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4189687,"threshold_uncertainty_score":0.9996982,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02605334179475607,"score_gpt":0.3776716080813189,"score_spread":0.3516182662865628,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}